Biotech Penny Stocks Remain A Focus Heading Into Q3 2021

Penny stocks are well known for their high risk and high reward potential. There aren’t many places where you can buy into an early-stage company, see shares rise 100% or more, and take profit all within a single day or week. Traders seek catalysts for potential moves then speculate on that catalyst ahead of time, in many cases. This can be something like upcoming earnings results, pending retail data, or, in the case of biotech stocks, upcoming FDA decisions, or trial data.

Compared to companies in the materials sector, retail, or even energy, biotech companies tend to pre-announce news. What I mean by this is that you’ll frequently see these companies release news of when they expect to report an event. Again this might be an FDA decision, trial data, “additional trial data,” an industry presentation, or something else. It’s one of the unique things about biotech that attracts momentum hunters.

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Release Pending for ‘Ever Given’

A representative for the owners and insurers of the massive cargo ship, Ever Given, says an “agreement in principle” has been reached with the Suez Canal Authority (SCA), CNN reports. In a statement, director Faz Peermohamed of Stann Marine, says the two sides are securing the last details of the pact following weeks of discussions. “We are now working […]

Read More
Business

A Couple Accidentally Planted One of the World’s Most Expensive Mangoes and Now Need Private Security

Sometimes wealth is the product of effort and hard work, and other times it is mere luck. The latter seems to apply to Rani and Sankalp Parihar, who accidentally planted some of the most expensive mangoes in the world. Now they have Miyazaki mango trees whose cost per kilogram is around 270,000 rupees (about $3,630). […]

Read More